Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hazard Ratio01:12

Hazard Ratio

462
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
462
Pharmacovigilance01:19

Pharmacovigilance

1.5K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K
Odds Ratio01:09

Odds Ratio

1.3K
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
1.3K
Relative Risk01:12

Relative Risk

1.5K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.5K
Sign Test for Matched Pairs01:17

Sign Test for Matched Pairs

333
The sign test for matched pairs offers a robust method for comparing two paired samples, often for the effects of an intervention in one of them. This method is very useful in situations where the underlying distribution of the data is unknown. The test compares two related samples—often pre- and post-treatment measurements on the same subjects—to determine if there are significant differences in their median values.
To conduct the sign test, we first calculate the differences in...
333
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

316
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
316

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commensurate prior models with random effects for interval-censored data to accommodate historical controls.

Communications in statistics: Simulation and computation·2026
Same author

Adoption and Regional Variation of Prostate-Specific Membrane Antigen Positron Emission Tomography in the United States.

JCO oncology practice·2026
Same author

A Bayesian framework for safety signal detection from medical device data.

Journal of biopharmaceutical statistics·2025
Same author

False-Positive Circulating Tumor DNA Results Do Not Explain Lack of Efficacy for PARP Inhibitors in Patients With Castration-Resistant Prostate Cancer Harboring <i>ATM</i> and <i>CHEK2</i> Mutations.

JCO precision oncology·2024
Same author

Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With <i>BRCA</i>-Mutated Metastatic Castration-Resistant Prostate Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

Related Experiment Video

Updated: Dec 17, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

717

Evaluating medical device adverse event signals using a likelihood ratio test method.

Zhiheng Xu1, Jianjin Xu1, Zhihao Yao1

  • 1Center for Devices and Radiology Health, U.S. Food and Drug Administration, MD, USA.

Journal of Biopharmaceutical Statistics
|June 30, 2020
PubMed
Summary

A likelihood ratio test (LRT) method effectively identified 18 adverse event (AE) signals, including bleeding risks, in left ventricular assist device (LVAD) data. This statistical approach offers a conservative and reliable tool for medical device post-market surveillance.

Keywords:
Medical device reportingadverse eventlikelihood-ratio testsignal detection

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.8K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.2K

Related Experiment Videos

Last Updated: Dec 17, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

717
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.8K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.2K

Area of Science:

  • Medical device safety
  • Pharmacovigilance
  • Biostatistics

Background:

  • Signal detection methods are crucial for post-market surveillance of adverse events (AEs).
  • Statistical methods for AE signal detection are underutilized in medical device safety monitoring.
  • Left ventricular assist devices (LVADs) require robust methods for identifying potential safety concerns.

Purpose of the Study:

  • To evaluate the efficacy of a likelihood ratio test (LRT)-based method for detecting AE signals in LVADs.
  • To apply LRT to Medical Device Reporting (MDR) data for identifying specific safety concerns.
  • To compare the performance of LRT against other established signal detection methods.

Main Methods:

  • Utilized a likelihood ratio test (LRT) for signal detection on 110,927 LVAD adverse event entries from MDR data.
  • Applied LRT to longitudinal data (2007-2019) with an alpha-spending function for trend analysis and type I error control.
  • Compared LRT performance against Proportional Reporting Ratios (PRRs), Bayesian Confidence Propagation Neural Network (BCPNN), and simplified Bayes methods.

Main Results:

  • The LRT method identified 18 distinct AE signals from the LVAD MDR data.
  • Seven of the detected signals were related to bleeding events, including hemolysis, thrombosis, and hemorrhage.
  • LRT demonstrated the most conservative performance among the compared methods, effectively controlling type I error and false discovery rates.

Conclusions:

  • The likelihood ratio test (LRT) is a valuable and conservative statistical method for detecting adverse event signals in medical device data, specifically for LVADs.
  • LRT provides reliable identification of safety signals, including critical bleeding-related events, enhancing post-market surveillance.
  • The LRT method's ability to control statistical errors makes it a robust tool for ensuring the safety and effectiveness of medical devices.